Imunon (IMNN) 10-Q2010 Q2 Quarterly report

Filed: 3 Aug 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advance, Affordable, alliance, ash, assist, biopharmaceutical, Biotech, Cap, case, CEFF, certainty, choose, climate, collaborative, conjunction, consecutive, contingent, daily, declared, delisted, delivery, discretion, dispose, dollar, Education, equivalent, exempt, exemption, external, flow, footnote, forecast, fulfilling, half, ial, indirectly, intentionally, jeopardize, lesser, long, mater, maximum, od, omitted, order, outlined, percent, percentage, Peri, portfolio, preserve, pro, promulgated, rata, read, satisfy, SCBV, senior, shelf, SHO, sponsored, stage, stra, stronger, swap, table, tegic, tion, tra, variety, waived, worth

Removed: America, award, check, Comparison, dividing, II, mark, measured, past, summarized

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IMNN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CELSION CORPORATION

CERTIFICATION

PURSUANT TO 18 UNITED STATES CODE § 1350

The undersigned hereby certifies that the Quarterly Report on Form 10-Q for the period ended June 30, 2010 of Celsion Corporation (the “Company”) filed with the Securities and Exchange Commission on the date hereof fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.



August 3, 2010	By:	/s/ Michael H. Tardugno
		Michael H. Tardugno
		President and Chief Executive Officer



August 3, 2010	By:	/s/ Jeffrey W. Church
		Jeffrey W. Church
		Vice President and Chief Financial Officer